BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND KDSR, Q06136, 2531, ENSG00000119537, FVT1
6 results:

  • 1. Long-term nationwide trends in the treatment of and outcomes among pancreatic cancer patients.
    Aaltonen P; Carpén O; Mustonen H; Puolakkainen P; Haglund C; Peltola K; Seppänen H
    Eur J Surg Oncol; 2022 May; 48(5):1087-1092. PubMed ID: 34844817
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest).
    Modlin IM; Kidd M; Oberg K; Falconi M; Filosso PL; Frilling A; Malczewska A; Salem R; Toumpanakis C; Laskaratos FM; Partelli S; Roffinella M; von Arx C; Kudla BK; Bodei L; Drozdov IA; Kitz A
    Ann Surg Oncol; 2021 Nov; 28(12):7506-7517. PubMed ID: 34008138
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. 1.0T MR-guided percutaneous coaxial cutting needle biopsy in pancreatic lesion diagnosis.
    Liu C; Wang L; He X; Xu Y; Lu D; Li P; Lv R; Feng Y; Liu M; Li C
    J Magn Reson Imaging; 2018 Aug; 48(2):382-388. PubMed ID: 29319916
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma.
    Reni M; Balzano G; Zanon S; Passoni P; Nicoletti R; Arcidiacono PG; Pepe G; Doglioni C; Fugazza C; Ceraulo D; Falconi M; Gianni L
    Br J Cancer; 2016 Jul; 115(3):290-6. PubMed ID: 27404453
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pre-operative cardiopulmonary exercise testing predicts adverse post-operative events and non-progression to adjuvant therapy after major pancreatic surgery.
    Chandrabalan VV; McMillan DC; Carter R; Kinsella J; McKay CJ; Carter CR; Dickson EJ
    HPB (Oxford); 2013 Nov; 15(11):899-907. PubMed ID: 23458160
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors.
    Massironi S; Conte D; Sciola V; Spampatti MP; Ciafardini C; Valenti L; Rossi RE; Peracchi M
    Am J Gastroenterol; 2010 Sep; 105(9):2072-8. PubMed ID: 20372113
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.